Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings
CNBC Earnings
Barrons Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

Stocktwits
MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-

Enliven Therapeutics, Inc. Common Stock | ELVN

AI Analysis of Enliven Therapeutics, Inc. Common Stock

Investors didn't show much interest in one Enliven Therapeutics way or another today. It hasn't moved too much today but is slightly down, it lost -0.41% since yesterday. It looks like ELVN could be hitting an upward sloping resistance line. Most traders won't try to short a stock when the line is upsloping. But it may be a good time to take profit or wait for a better entry point for a long position. Enliven Therapeutics has been drifting up over the last few months, we'll see if it has the energy to break through or if buyers decide to take profit.

If it breaks through the resistance level, we aren't seeing any clear resistance points beyond that. So it may have plenty of room to work up from there. If the price reverses and heads back down lower, it looks like the nearest support level is $33.63 it may head back up from there or break lower.


Last analyzed on 2026-07-23

Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-